Cancer
Color or money?: The impact of socioeconomic status and race/ethnicity on breast cancer mortality
[ad_1]
Background:
Although the incidence of breast cancer is highest in White women, Black women die at a high...
Disparities in awareness of and willingness to participate in cancer clinical trials between African American and White cancer survivors
[ad_1]
Background:
Cancer clinical trials (CCTs) are essential for cancer care, yet the evidence is scarce when...
Interventions to increase racial and ethnic minority accrual into cancer clinical trials: A systematic review
[ad_1]
Background:
Racial and ethnic minorities (REMs) continue to be underrepresented in clinical trials despi...
Family functioning and psychosocial symptoms among Latinx patients coping with advanced cancer
[ad_1]
Objectives:
This brief report aims to describe and determine the association of family functioning (e.g., cohesion and expressiveness) wi...
Crwe World | Aspira Women’s Health Announces Publication of its Second-Generation MultiVariate Index Assay, OVERA®, in the Detection of Cancer in F...
[ad_1]
Data demonstrates the accuracy of Aspira’s multivariate assessment test OVERA in a non-White population and concludes use of OVERA to be b...
Enrollment of Individuals From Racial and Ethnic Minority Groups in Gynecologic Cancer Precision Oncology Trials
[ad_1]
Objective:
To characterize whether enrollment patterns in precision oncology clinical trials for gynecol...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
